Vimarsana
Biggest News Aggregation in the World

Qualification Consortium News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Qualification Consortium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Qualification Consortium Today - Breaking & Trending Today

Drug Candidate for Schizophrenia, Alzheimer Disease Approved to Initiate Phase 2 Trial in Q2 2024 - Vimarsana News

Drug Candidate for Schizophrenia, Alzheimer Disease Approved to Initiate Phase 2 Trial in Q2 2024

The candidate also aims to address neurodevelopmental and neurodegenerative disorders such as Parkinson disease and Rett syndrome.

Pharma Consortium Publishes Results of Large EEG/ERP Biomarker Study in Subjects with Schizophrenia and Healthy Volunteers - Vimarsana News

Pharma Consortium Publishes Results of Large EEG/ERP Biomarker Study in Subjects with Schizophrenia and Healthy Volunteers

/PRNewswire/ -- The ERP Biomarker Qualification Consortium announced today the publication of all data (https://doi.org/10.1016/j.schres.2023.02.018) from a...

Pharma Industry Consortium Completes Brain Wave Study of Ketamine Effects on Healthy Volunteers - Vimarsana News

Pharma Industry Consortium Completes Brain Wave Study of Ketamine Effects on Healthy Volunteers

/PRNewswire/ -- The ERP Biomarker Qualification Consortium announced today the successful completion of a pharma industry-sponsored study to measure the...